Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment - A comparative study

Transfusion and Apheresis Science

Volumn 49, Issue 3, 2013, Pages 434-439

  Balint, Bela ^a,b,c   Jovicic Gojkov, Dragana ^b   Todorovic Balint, Milena ^a,d   Subota, Vesna ^b,c   Pavlovic, Mirjana ^e   Goodrich, Raymond ^f  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c Faculty of Medicine   (Serbia)

^d CLINICAL CENTER OF SERBIA   (Serbia)

^e FLORIDA ATLANTIC UNIVERSITY   (United States)

^f Terumo BCT   (United States)

Author keywords

Plasma; Riboflavin; Ultraviolet light; Virus inactivation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; ELECTROLYTE; FRESH FROZEN PLASMA; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; PLASMA PROTEIN; PROCOAGULANT; PROTEIN C; PROTHROMBIN; RIBOFLAVIN; UREA;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CENTRIFUGATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HEMOSTASIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; NORMAL HUMAN; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; STORAGE; ULTRAVIOLET RADIATION; UREA BLOOD LEVEL;

PLASMA; RIBOFLAVIN; ULTRAVIOLET LIGHT; VIRUS INACTIVATION;

ADOLESCENT; ADULT; AGED; BLOOD PRESERVATION; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMA; RIBOFLAVIN; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84888434687     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.05.035     Document Type: Article

References (14)

1. McCullough J. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections. Am J Clin Pathol 2007, 128:945-955.
2. Klein H.G., Glynn S.A., Ness P.M., Blajchman M.A. Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop. Transfusion 2009, 49:1262-1268.
3. Pelletier J.P., Transue S., Snyder E.L. Pathogen inactivation techniques. Best Pract Res Clin Haematol 2006, 19:205-242.
4. Balint B., Ilic V., Taseski J., Vucetic D. Prevention of transfusion related immunomodulation by ultraviolet irradiation. Anest Reanim Transfus [Serbian] 1998, 27:5-11.
5. Jocic M., Trkuljic M., Jovicic D., Borovcanin N., Balint B. Inactivation effecacy of Mirasol PRT in platelet concentrates using bacteria-contamination model. Vojnosanit Pregl 2011, 68(12):1041-1046.
6. Goodrich R.P., Doane S., Reddy H.L. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010, 38:20-30.
7. Klein H.G., Anderson D., Bernardi M.J., Cable R., Carey W., Hoch J.S., et al. Pathogen inactivation: making decisions about new technologies. Transfusion 2007, 47:2338-2347.
8. Stanojkovic Z., Balint B., Antic A., Todorovic M., Pavlovic M., Subota V., et al. Clinical efficacy of riboflavin and ultraviolet light inactivated fresh frozen plasma assessed using INR-quantification. Transf Apher Sci 2012, 47:33-37.
9. Bihm D.J., Ettinger A., Buytaert-Hoefen K.A., Hendrix B.K., Maldonado-Codina G., Rock G., et al. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30°C. Vox Sang 2010, 98:108-115.
10. Balint B., Pavlovic M., Jevtic M., Hrvacevic R., Ostojic G., Ignjatovic Lj, et al. Simple closed-circuit group-specific immunoadsorption system for ABO-incompatible kidney transplants. Transf Apher Sci 2007, 36:225-233.
11. Balint B., Pavlovic M., Todorovic M., Jevtic M., Ristanovic E., Ignjatovic Lj The use of simplified ex vivo immunoadsorption and "multi-manner" apheresis in ABO/H-mismatched kidney transplant setting - phase II clinical study. Transf Apher Sci 2010, 43(2):141-148.
12. Rock G. A comparison of methods of pathogen inactivation of FFP. Vox Sang 2011, 100(2):169-178.
13. Smith J., Rock G. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma. Transfusion 2010, 50:926-931.
14. Hornsey V.S., Drummond O., Morrison A., McMillan L., MacGregor I.R., Prowse C.V. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins. Transfusion 2009, 49:2167-2172.